Kukdo Chemical (007690)
Korea Stock Exchange · Korea · prices in KRW · close of 23 Oct 2026
Key indicators
| Last close | KRW 29,900.00 |
|---|---|
| 52-week range | 29,050.00 – 44,450.00 |
| Return, 1 month / 3 months | −18.8% / −24.2% |
| Return, 1 year / 3 years | −13.2% / −14.3% |
| Trend | Below its 200-day average |
| RSI (14) | 21 |
| Volatility (1 year) | 46.4% |
| Worst drawdown (1 year) | -32.6% |
| Average daily value traded | 832.97M KRW |
| Dividend yield | 4.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Kukdo Chemical is a Korean chemical manufacturer that makes epoxy resins and polyurethane raw materials, including polyols and related intermediates. Its products are used in coatings, adhesives, electrical and electronic components, composites and construction materials. The company serves industrial customers that process these materials into finished goods, and it is based in Seoul, Korea. Its business centres on supplying specialty chemicals rather than consumer products, with customers drawn from manufacturing sectors that depend on durable, high-performance materials.
Kukdo Chemical trades under the code 007690 on the Korea Stock Exchange in Korea, with its price quoted in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Kukdo Chemical (007690) trades on the Korea Stock Exchange in Korea. It last closed at KRW 29,900.00 on 23 October 2026.
Its price-based Market X-Ray is 56 out of 100 (a fair price profile), ranking 372 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 13.2% and over the last three months it fell 24.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 61 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -18.0% | ||
| From 52-week high | -32.6% | ||
| Momentum | 40 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -24.2% | ||
| 6-month return | -26.6% | ||
| 12-month return, skipping the last month | 6.8% | ||
| Stability (higher is calmer) | 65 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 46.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.6% | ||
| Liquidity | 55 · Fair | Moderate trading activity. | |
| Average daily value traded | 832.97M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 59 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.3% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −8.3% |
|---|---|
| 1 month | −18.8% |
| 3 months | −24.2% |
| 6 months | −26.6% |
| 1 year | −13.2% |
| 3 years | −14.3% |
| 5 years | −47.3% |
Signals
| 50-day / 200-day average | 37,451.00 / 36,448.24 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1,447.95 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Mar 2026 | KRW 1,300.0000 |
| 7 Mar 2025 | KRW 600.0000 |
| 27 Dec 2023 | KRW 1,200.0001 |
| 28 Dec 2022 | KRW 1,400.0000 |
| 29 Dec 2021 | KRW 2,200.0001 |
| 29 Dec 2020 | KRW 1,137.3631 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.